跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
METRONIDAZOL/ESPIRAMICINA FARMALIDER 250 MG/1,5 MUI COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
METRONIDAZOL/ESPIRAMICINA FARMALIDER 250 MG/1,5 MUI COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
METRONIDAZOL/ESPIRAMICINA FARMALIDER 250 MG/1,5 MUI COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Farmalider S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 31, 2022
Approval ID
9e5c68f714f27b12
Company
Farmalider S.A.
Type
Standard
Approval Details
Approval Id
9e5c68f714f27b12
Drug Cima Aemps Name
METRONIDAZOL/ESPIRAMICINA FARMALIDER 250 MG/1,5 MUI COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
86717
Holder Company Name
Farmalider S.A.
Marketing Company Name
Farmalider S.A.
Authorization Date
2022-03-31
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
250 mg/1,5 MILLONES DE UI
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Farmalider S.A.
Active Ingredients
ESPIRAMICINA
1,5 MILLONES UI
METRONIDAZOL
250 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 31, 2022
Approval ID
9e5c68f714f27b12
Type
Standard
Back to CIMA-AEMPS Approvals